218 related articles for article (PubMed ID: 37338617)
1. Association of Antibody Responses to Fusobacterium nucleatum and Streptococcus gallolyticus Proteins with Colorectal Adenoma and Colorectal Cancer.
Genua F; Butt J; Waterboer T; Hughes DJ
Dig Dis Sci; 2023 Aug; 68(8):3300-3311. PubMed ID: 37338617
[TBL] [Abstract][Full Text] [Related]
2. Serology of Streptococcus gallolyticus subspecies gallolyticus and its association with colorectal cancer and precursors.
Butt J; Werner S; Willhauck-Fleckenstein M; Michel A; Waterboer T; Zörnig I; Boleij A; Dramsi S; Brenner H; Pawlita M
Int J Cancer; 2017 Sep; 141(5):897-904. PubMed ID: 28477334
[TBL] [Abstract][Full Text] [Related]
3. Detection of
Périchon B; Lichtl-Häfele J; Bergsten E; Delage V; Trieu-Cuot P; Sansonetti P; Sobhani I; Dramsi S
Front Cell Infect Microbiol; 2022; 12():794391. PubMed ID: 35360109
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer.
Butt J; Jenab M; Willhauck-Fleckenstein M; Michel A; Pawlita M; Kyrø C; Tjønneland A; Boutron-Ruault MC; Carbonnel F; Severi G; Kaaks R; Kühn T; Boeing H; Trichopoulou A; la Vecchia C; Karakatsani A; Panico S; Tumino R; Agnoli C; Palli D; Sacerdote C; Bueno-de-Mesquita HBA; Weiderpass E; Sánchez MJ; Bonet Bonet C; Huerta JM; Ardanaz E; Bradbury K; Gunter M; Murphy N; Freisling H; Riboli E; Tsilidis K; Aune D; Waterboer T; Hughes DJ
Int J Cancer; 2018 Jul; 143(2):245-252. PubMed ID: 29377173
[TBL] [Abstract][Full Text] [Related]
5.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
6. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
7. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
8. Antibody Responses to
Butt J; Blot WJ; Teras LR; Visvanathan K; Le Marchand L; Haiman CA; Chen Y; Bao Y; Sesso HD; Wassertheil-Smoller S; Ho GY; Tinker LF; Peek RM; Potter JD; Cover TL; Hendrix LH; Huang LC; Waterboer T; Pawlita M; Epplein M
Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1186-1194. PubMed ID: 30038049
[No Abstract] [Full Text] [Related]
9. Association of Streptococcus gallolyticus subspecies gallolyticus with colorectal cancer: Serological evidence.
Butt J; Romero-Hernández B; Pérez-Gómez B; Willhauck-Fleckenstein M; Holzinger D; Martin V; Moreno V; Linares C; Dierssen-Sotos T; Barricarte A; Tardón A; Altzibar JM; Moreno-Osset E; Franco F; Requena RO; Huerta JM; Michel A; Waterboer T; Castaño-Vinyals G; Kogevinas M; Pollán M; Boleij A; de Sanjosé S; Del Campo R; Tjalsma H; Aragonés N; Pawlita M
Int J Cancer; 2016 Apr; 138(7):1670-9. PubMed ID: 26537841
[TBL] [Abstract][Full Text] [Related]
10. Intestinal microbiota and its association with colon cancer and red/processed meat consumption.
Abu-Ghazaleh N; Chua WJ; Gopalan V
J Gastroenterol Hepatol; 2021 Jan; 36(1):75-88. PubMed ID: 32198788
[TBL] [Abstract][Full Text] [Related]
11. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
12. The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue.
Bundgaard-Nielsen C; Baandrup UT; Nielsen LP; Sørensen S
BMC Cancer; 2019 Apr; 19(1):399. PubMed ID: 31035942
[TBL] [Abstract][Full Text] [Related]
13. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
14. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
[TBL] [Abstract][Full Text] [Related]
15. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
[TBL] [Abstract][Full Text] [Related]
16. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
17. Antibody Responses to
Butt J; Jenab M; Pawlita M; Overvad K; Tjonneland A; Olsen A; Boutron-Ruault MC; Carbonnel F; Mancini FR; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Palli D; Pala VM; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita B; van Gils CH; Vermeulen RCH; Weiderpass E; Quirós JR; Duell EJ; Sánchez MJ; Dorronsoro M; Huerta JM; Ardanaz E; Van Guelpen B; Harlid S; Perez-Cornago A; Gunter MJ; Murphy N; Freisling H; Aune D; Waterboer T; Hughes DJ
Cancer Epidemiol Biomarkers Prev; 2019 Sep; 28(9):1552-1555. PubMed ID: 31481495
[TBL] [Abstract][Full Text] [Related]
18. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
[TBL] [Abstract][Full Text] [Related]
19.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
